These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 390247)

  • 1. Immunological studies in thromboangitis obliterans (Buerger's disease).
    Gulati SM; Singh KS; Thusoo TK; Saha K
    J Surg Res; 1979 Nov; 27(5):287-93. PubMed ID: 390247
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulins and complement 3 in patients with thromboangitis obliterans.
    Dasgupta A; Roy MB; Talwar JR; Kapur BM
    Indian J Med Res; 1978 Feb; 67():332-5. PubMed ID: 680892
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of circulatory immune complexes in thromboangiitis obliterans (Buerger's disease).
    Gulati SM; Saha K; Kant L; Thusoo TK; Prakash A
    Angiology; 1984 May; 35(5):276-81. PubMed ID: 6426348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immune response to Buerger's disease.
    Ehteshamfar SM; Afshari JT; Modaghegh MS; Mahmoudi M; Kazemzadeh GH; Kermani FS
    Vascular; 2020 Aug; 28(4):457-464. PubMed ID: 32212917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aspects of thromboangiitis obliterans (von Winiwarter-Buerger's disease).
    Berlit P; Kessler C; Reuther R; Krause KH
    Eur Neurol; 1984; 23(6):394-9. PubMed ID: 6391927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in thromboangiitis obliterans (Buerger's disease).
    Gulati SM; Madhra K; Thusoo TK; Nair SK; Saha K
    Angiology; 1982 Oct; 33(10):642-51. PubMed ID: 6751163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticardiolipin antibodies in patients with Buerger's disease].
    Cnotliwy M; Gutowski P; Szumiłowicz H; Kucharska E; Jastrzebska M; Ostanek L
    Wiad Lek; 1999; 52(7-8):332-6. PubMed ID: 10540577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease).
    Smolen JS; Youngchaiyud U; Weidinger P; Kojer M; Endler AT; Mayr WR; Menzel EJ
    Clin Immunol Immunopathol; 1978 Oct; 11(2):168-77. PubMed ID: 367656
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum immunoglobulins in patients with arteriosclerosis & thromboangitis obliterans.
    Sooch N; Goyal A; Abbey RK; Gupta MK; Gupta RR
    Indian J Med Res; 1987 Jan; 85():49-52. PubMed ID: 3583356
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating immune complexes in Buerger's disease. Endarteritis obliterans in young men.
    Roncon de Albuquerque R; Delgado L; Correia P; Torrinha JF; Serrão D; Braga A
    J Cardiovasc Surg (Torino); 1989; 30(5):821-5. PubMed ID: 2808505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies on thromboangiitis obliterans.
    Zheng P; Fu PB; Wang WC; Xu WY; Tang XM; Ye M; Chen ZR
    Chin Med J (Engl); 1989 Feb; 102(2):129-36. PubMed ID: 2505978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view.
    Kobayashi M; Sugimoto M; Komori K
    Circ J; 2014; 78(12):2819-26. PubMed ID: 25298073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboangiitis obliterans: an old disease in need of a new look.
    Adar R; Papa MZ; Schneiderman J
    Int J Cardiol; 2000 Aug; 75 Suppl 1():S167-70; discussion S171-3. PubMed ID: 10980358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger's disease)?
    Olin JW
    Vasc Med; 2002; 7(4):257-8. PubMed ID: 12710839
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular sensitivity to collagen in thromboangiitis obliterans.
    Adar R; Papa MZ; Halpern Z; Mozes M; Shoshan S; Sofer B; Zinger H; Dayan M; Mozes E
    N Engl J Med; 1983 May; 308(19):1113-6. PubMed ID: 6835334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboangitis obliterans (Buerger's disease).
    ROGERS KF
    J Can Med Serv; 1946 Mar; 3():286-8. PubMed ID: 21019786
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and treatment of thromboangitis obliterans (Buerger's disease).
    BARKER NW
    Minn Med; 1956 May; 39(5):303-6. PubMed ID: 13321746
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thromboangitis obliterans in Korea. (Re-evaluation of Buerger's disease)].
    LEE YK
    Taehan Uihak Hyophoe Chi; 1962 May; 5():266-73. PubMed ID: 14463592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.